José Luís
Zamorano Gómez
Catedrático/a de Universidad
![Foto de José Luís](/img/nophoto.png)
![Foto de Medical University of Vienna](/img/noimage_org.png)
Medical University of Vienna
Viena, AustriaMedical University of Vienna-ko ikertzaileekin lankidetzan egindako argitalpenak (19)
2024
-
Prognostic Implications of Residual Tricuspid Regurgitation Grading After Transcatheter Tricuspid Valve Repair
JACC: Cardiovascular Interventions, Vol. 17, Núm. 12, pp. 1485-1495
-
TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation
European heart journal, Vol. 45, Núm. 8, pp. 586-597
-
Tricuspid valve disease and cardiac implantable electronic devices
European Heart Journal, Vol. 45, Núm. 5, pp. 346-365
2022
-
6-Month Outcomes of the TricValve System in Patients With Tricuspid Regurgitation: The TRICUS EURO Study
JACC: Cardiovascular Interventions, Vol. 15, Núm. 13, pp. 1366-1377
-
Tricuspid regurgitation: recent advances in understanding pathophysiology, severity grading and outcome
European heart journal. Cardiovascular Imaging, Vol. 23, Núm. 7, pp. 913-929
2021
-
Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry
Internal and Emergency Medicine, Vol. 16, Núm. 3, pp. 591-599
-
Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR
New England Journal of Medicine, Vol. 385, Núm. 23, pp. 2150-2160
-
European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions
EuroIntervention, Vol. 17, Núm. 5, pp. E367-E375
-
European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions
European Heart Journal, Vol. 42, Núm. 16, pp. 1545-1553
2020
-
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS)
European Heart Journal, Vol. 41, Núm. 4, pp. 543-603
-
Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)
European Journal of Heart Failure, Vol. 22, Núm. 9, pp. 1504-1524
2019
-
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)
European Respiratory Journal, Vol. 54, Núm. 3
-
European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism
European Heart Journal, Vol. 40, Núm. 38, pp. 3182-3195
2016
-
Recommendations for the imaging assessment of prosthetic heart valves: A report from the European Association of Cardiovascular Imaging endorsed by the Chinese Society of Echocardiography, the Inter-American Society of Echocardiography, and the Brazilian Department of Cardiovascular Imaging
European Heart Journal Cardiovascular Imaging, Vol. 17, Núm. 6, pp. 589-590
2014
-
Appropriateness criteria for cardiovascular imaging use in clinical practice: A position statement of the ESC/EACVI taskforce
European Heart Journal Cardiovascular Imaging, Vol. 15, Núm. 5, pp. 477-482
-
Updated standards and processes for accreditation of echocardiographic laboratories from The European Association of Cardiovascular Imaging: An executive summary
European Heart Journal Cardiovascular Imaging, Vol. 15, Núm. 11, pp. 1188-1193
-
Updated standards and processes for accreditation of echocardiographic laboratories from the European Association of Cardiovascular Imaging
European Heart Journal Cardiovascular Imaging, Vol. 15, Núm. 7, pp. 717-727
2013
-
Normal Reference Ranges for Echocardiography: Rationale, study design, and methodology (NORRE Study)
European Heart Journal Cardiovascular Imaging, Vol. 14, Núm. 4, pp. 303-308
-
Vandetanib in advanced medullary thyroid cancer: Review of adverse event management strategies
Advances in Therapy, Vol. 30, Núm. 11, pp. 945-966